[1] Newsome PN,King R,Fox A,et al. A multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony stimulating factor mobilised CD133+ bone marrow stem cells in patients with cirrhosis. J Hepatology,2016,64:s133-s211. [2] Peng L,Xie DY,Lin BL,et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes.Hepatology,2011,54: 820-828. [3] Fu QC, Jiang S, Wang XJ, et al. Escalation study of umbilical cord mesenchymal stem cells intravenously transfusion in patients with decompensated cirrhosis. J Hepatology,2013,58:s35. |